All Stories

  1. Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward Trial
  2. Body composition changes in women with early breast cancer after adjuvant treatment: a systematic review
  3. Levels of plasma 25-hydroxy vitamin D and risk of developing type 2 diabetes in a large Danish primary health care population
  4. Diurnal fluctuations in biochemical parameters related to calcium homeostasis – the Bispebjerg study of diurnal variations
  5. Development of an App for Symptom Management in Women With Breast Cancer Receiving Maintenance Aromatase Inhibitors: Protocol for a Mixed Methods Feasibility Study
  6. Measurement of plasma total calcium before plasma free ionized calcium – a possibility with affordable pitfalls
  7. Psychological impairment in inflammatory bowel diseases: the key role of coping and defense mechanisms
  8. Single zoledronic acid infusion as a cause of acute kidney impairment requiring dialysis in two patients with osteoporosis
  9. Development of an App for Symptom Management in Women With Breast Cancer Receiving Maintenance Aromatase Inhibitors: Protocol for a Mixed Methods Feasibility Study (Preprint)
  10. Peripheral blood mononuclear cells exhibit increased mitochondrial respiration after adjuvant chemo- and radiotherapy for early breast cancer
  11. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report
  12. Weight Change in Post-Menopausal Women with Breast Cancer during Chemotherapy—Perspectives on Nutrition, Activity and Bone Metabolism: An Interim Analysis of a 5-Year Prospective Cohort
  13. Anxiety Levels Predict Bone Mineral Density in Postmenopausal Women Undergoing Oral Bisphosphonates: A Two-Year Follow-Up
  14. RANKL regulates male reproductive function
  15. Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial
  16. Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer
  17. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
  18. Vitamin D levels and cancer incidence in 217,244 individuals from primary health care in Denmark
  19. Effect of chemotherapy and aromatase inhibitors in the adjuvant treatment of breast cancer on glucose and insulin metabolism-A systematic review
  20. Chronic Non-bacterial Osteomyelitis: A Review
  21. The association of celiac disease and allergic disease in a general adult population
  22. FRAX Calculated without BMD Resulting in a Higher Fracture Risk Than That Calculated with BMD
  23. Clinical improvement in a patient with monostotic melorheostosis after treatment with denosumab: a case report
  24. Identification and Functional Characterization of a Novel Mutation in the Human Calcium-Sensing Receptor That Co-Segregates With Autosomal-Dominant Hypocalcemia
  25. Modulation of the sympathetic nervous system in youngsters by vitamin-D supplementation
  26. The role of the P2X7 receptor on bone loss in a mouse model of inflammation-mediated osteoporosis
  27. P2Y12 Receptor Antagonist, Clopidogrel, Does Not Contribute to Risk of Osteoporotic Fractures in Stroke Patients
  28. Evidence for the prevention of bone loss in elderly and old early non-metastatic breast cancer patients treated with aromatase inhibitors
  29. Erratum to: determinants of vitamin D status in young adults: influence of lifestyle, sociodemographic and anthropometric factors
  30. P2X7Rs are involved in cell death, growth and cellular signaling in primary human osteoblasts
  31. Letter to the Editor Response: The J-shaped 25-hydroxyvitamin D concentration/CVD-mortality relation is an artifact caused by lack of correction due to age, by Steen Ahrenkiel
  32. Determinants of vitamin D status in young adults: influence of lifestyle, sociodemographic and anthropometric factors
  33. Physical exercise associated with improved BMD independently of sex and vitamin D levels in young adults
  34. Real-Life and RCT Participants: Alendronate Users Versus FITs’ Trial Eligibility Criterion
  35. Vertebral fracture assessment by DXA is inferior to X-ray in clinical severe osteoporosis
  36. Fine-tuned ATP signals are acute mediators in osteocyte mechanotransduction
  37. Perceived age is associated with bone status in women aged 25–93 years
  38. Is allopurinol use associated with an excess risk of osteoporotic fracture? A National Prescription Registry study
  39. The Influence of Clinical Experience and Photographic Presentation on Age Assessment of Women
  40. Serum 25-hydroxyvitamin D and self-reported mental health status in adult Danes
  41. A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study
  42. Response to the letter by Grant
  43. Association between leukocyte telomere length and bone mineral density in women 25–93years of age
  44. Screening for celiac disease in Danish adults
  45. The PRIMARA study to review cinacalcet use in patients with primary hyperparathyroidism
  46. Muscle strength, power and cardiorespiratory fitness are associated with bone mineral density in men aged 31–60 years
  47. A review of lifestyle, smoking and other modifiable risk factors for osteoporotic fractures
  48. Epidemiology of forearm fractures in adults in Denmark: national age- and gender-specific incidence rates, ratio of forearm to hip fractures, and extent of surgical fracture repair in inpatients and outpatients
  49. Genetic variants in theP2RX7gene are associated with risk of multiple myeloma
  50. Non-infectious osteomyelitis of the mandible in a young woman: a case report
  51. Status of drug development for the prevention and treatment of osteoporosis
  52. The P2X7 Receptor: A Key Player in Immune-Mediated Bone Loss?
  53. UTP-induced ATP release is a fine-tuned signalling pathway in osteocytes
  54. The effect of PTH(1-34) on fracture healing during different loading conditions
  55. A Standardized Vascular Disease Health Check in Europe: A Cost-Effectiveness Analysis
  56. Purinergic Signaling in Bone
  57. Low levels of vitamin D are associated with increased mortality in patients attending a university hospital in Denmark
  58. Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status
  59. Clopidogrel (Plavix), a P2Y12receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo
  60. Gastrointestinal Events with Clopidogrel: A Nationwide Population-Based Cohort Study
  61. Short-term teriparatide treatment does not affect NT-proBNP, a marker of cardiac disease
  62. Use of the oral platelet inhibitors dipyridamole and acetylsalicylic acid is associated with increased risk of fracture
  63. A Reverse J-Shaped Association of All-Cause Mortality with Serum 25-Hydroxyvitamin D in General Practice: The CopD Study
  64. Association of P2X7 receptor polymorphisms with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients
  65. Association of P2Y2 receptor SNPs with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients
  66. Secondary hyperparathyroidism and mortality in hip fracture patients compared to a control group from general practice
  67. Elevated liver enzymes, anaemia and osteopaenia in a young woman
  68. Paget's disease of the bone after treatment with Denosumab: A case report
  69. Clopidogrel and the risk of osteoporotic fractures: a nationwide cohort study
  70. Determinants of vitamin D status in a general population of Danish adults
  71. Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures
  72. Effects of Increasing Age, Dosage, and Duration of PTH Treatment on BMD Increase—A Meta-analysis
  73. Association between P2X7 Receptor Polymorphisms and Bone Status in Mice
  74. Genetic Background Strongly Influences the Bone Phenotype of P2X7 Receptor Knockout Mice
  75. Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series
  76. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans
  77. Effects of Anti-osteoporosis Medications on Fracture Healing
  78. Role of purinergic receptor polymorphisms in human bone
  79. The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men
  80. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution
  81. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
  82. Effect of a program of multifactorial fall prevention on health-related quality of life, functional ability, fear of falling and psychological well-being. A randomized controlled trial
  83. Parathyroid Hormone and Bone Healing
  84. Amylin(1–8) is Devoid of Anabolic Activity in Bone
  85. Glucocorticoid Induced Osteopenia in Cancellous Bone of Sheep
  86. Baseline and Follow-Up Characteristics of Participants and Nonparticipants in a Randomized Clinical Trial of Multifactorial Fall Prevention in Denmark
  87. An Outpatient Multifactorial Falls Prevention Intervention Does Not Reduce Falls in High-Risk Elderly Danes
  88. Protein-containing nutrient supplementation following strength training enhances the effect on muscle mass, strength, and bone formation in postmenopausal women
  89. Osteoporosis in chronic obstructive pulmonary disease patients
  90. Primary and Secondary Prophylaxis to the Use of Inhaled Glucocorticoid in Primary Health Care
  91. Mechanical Muscle Function, Morphology, and Fiber Type in Lifelong Trained Elderly
  92. Effects of treatment with fluoride on bone mineral density and fracture risk - a meta-analysis
  93. Tendon collagen synthesis at rest and after exercise in women
  94. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease—A cross sectional study
  95. Management of risk of glucocorticoid-induced osteoporosis due to systemic administration in general practice in Denmark
  96. Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk – a meta-analysis
  97. MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men—results from the Odense Androgen Study
  98. No effect of menstrual cycle on myofibrillar and connective tissue protein synthesis in contracting skeletal muscle
  99. Calcium-Sensing Receptor Induces Proliferation through p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase But Not Extracellularly Regulated Kinase in a Model of Humoral Hypercalcemia of Malignancy
  100. Editorial
  101. Calcium-Sensing Receptor Induces Messenger Ribonucleic Acid of Human Securin, Pituitary Tumor Transforming Gene, in Rat Testicular Cancer
  102. Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells
  103. The calcium-sensing receptor in human disease
  104. Rapid suppression of S-PTH by oral calcitriol and calcium in healthy premenopausal women
  105. Serum levels of parathyroid hormone and markers of bone metabolism in patients with rheumatoid arthritis. Relationship to disease activity and glucocorticoid treatment
  106. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism associated with mutations in the human Ca2+-sensing receptor gene in three Danish families
  107. The Vitamin D Receptor (VDR) Start Codon Polymorphism in Primary Hyperparathyroidism and Parathyroid VDR Messenger Ribonucleic Acid Levels1
  108. Evidence for a role of intracellular stored parathyroid hormone in producing hysteresis of the PTH–calcium relationship in normal humans
  109. Effect of nasal salmon calcitonin on posttraumatic osteopenia following ankle fracture: A randomized double-blind placebo-controlled study in 24 patients
  110. A mathematical/physiological model of parathyroid hormone secretion in response to blood-ionized calcium loweringin vivo
  111. Parathyroid hormone secretion in chronic renal failure
  112. Inter-relations between the calcium set-points of Parfitt and Brown in primary hyperparathyroidism: a sequential citrate and calcium clamp study
  113. Cica-clamp technique: a method for quantifying parathyroid hormone secretion: a sequential citrate and calcium clamp study
  114. Changing incidence and residual lifetime risk of common osteoporosis-related fractures
  115. Radial and humeral fractures as predictors of subsequent hip, radial or humeral fractures in women, and their seasonal variation
  116. Normal pattern of parathyroid response to blood calcium lowering in primary hyperparathyroidism: a citrate clamp study
  117. Induced hypocalcaemia and intact PTH responsiveness in patients with primary hyperparathyroidism, primary hypoparathyroidism and normal man
  118. Calcium clamp technique: Suppression of serum intact PTH by induced hypercalcaemia in normal man and primary hyperparathyroidism
  119. Induced hypocalcaemia controlled by a citrate clamp technique, and the intact parathyroid hormone response obtained